Type 2 diabetes prevention in the community: 12-Month outcomes from the Sydney Diabetes Prevention Program

被引:21
|
作者
Vita, Philip [1 ]
Cardona-Morrell, Magnolia [2 ,3 ]
Bauman, Adrian [2 ]
Singh, Maria Fiatarone [1 ]
Moore, Michael [4 ]
Pennock, Rene [5 ]
Snow, Jill
Williams, Mandy [6 ]
Jackson, Lilian [7 ]
Milat, Andrew [2 ,8 ]
Colagiuri, Stephen [1 ]
机构
[1] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney Med Sch, Sydney, NSW 2006, Australia
[2] Univ Sydney, Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW 2006, Australia
[3] Univ New S Wales, Simpson Ctr Hlth Serv Res, Sydney, NSW, Australia
[4] Inner West Sydney Medicare Local, Sydney, NSW 2131, Australia
[5] Sydney South West Medicare Local, Sydney, NSW 2560, Australia
[6] Sydney South West & Sydney Local Hlth Dist, Sydney, NSW 2170, Australia
[7] Diabet NSW, Sydney, NSW 2001, Australia
[8] New South Wales Minist Hlth, Sydney, NSW 2060, Australia
关键词
Diabetes prevention; Primary health care setting; Lifestyle modification; Research translation; LIFE-STYLE INTERVENTION; PHYSICAL-ACTIVITY; WEIGHT-LOSS; REAL-WORLD; FOLLOW-UP; RISK; CARE;
D O I
10.1016/j.diabres.2015.11.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis: The Sydney Diabetes Prevention Program (SDPP) was a community-based type 2 diabetes prevention translational research study with screening and recruitment in the primary health care setting. We aimed to investigate the program's effectiveness in reducing risk factors for diabetes as well as the program's reach, adoption and implementation. Methods: 1238 participants aged 50-65 years at high-risk of developing type 2 diabetes were recruited by primary care physicians in the greater Sydney region. The intervention, delivered by trained allied health professionals, included an initial consultation, three group sessions/individual sessions, three follow-up phone calls, and a final review at 12 months. Biomarkers and behavioural goals were compared between baseline and 12 months. Results: At baseline, the mean age of those who entered the program was 58.8 +/- 4.4 years, 63% female, and the mean body mass index was 31.6 +/- 5.2 kg/m(2). There was a significant weight reduction of 2 +/- 4.3 kg (p < 0.02) in the 850 participants who completed the 12-month follow-up accompanied by improvements in diet (total fat, saturated fat, and fibre intake) and physical activity. There were also significant reductions in waist circumference 2.6 +/- 4.7 cm (p < 0.001) and total cholesterol -0.2 +/- 0.8 mmol/L (p < 0.001) but not blood glucose. The diabetes risk reduction was estimated to be 30%, consistent with similar trials. Conclusions/interpretation: This study demonstrates that a community-based lifestyle modification program is effective in reducing important risk factors for diabetes in individuals at high-risk of developing type 2 diabetes. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
下载
收藏
页码:13 / 19
页数:7
相关论文
共 50 条
  • [21] Results of the Diabetes Prevention Program Outcomes Study: 15 years of type 2 Diabetes Prevention [Ergebnisse der Diabetes‑Prevention-Program‑Outcomes-Study: 15 Jahre Prävention des Diabetes mellitus Typ 2]
    Jecht M.
    Der Diabetologe, 2015, 11 (8): : 649 - 650
  • [22] Albuminuria and the risk of type 2 diabetes mellitus in the diabetes prevention program
    Friedman, A. N.
    Marrero, D.
    Rackermann, Y. M. A.
    Narayan, V.
    Barrett-Connor, E.
    Watson, K.
    Knowler, W.
    Horton, E.
    DIABETES, 2007, 56 : A603 - A603
  • [23] Translating the Diabetes Prevention Program Into Practice in the General Community Findings From the Montana Cardiovascular Disease and Diabetes Prevention Program
    Amundson, Helen A.
    Butcher, Marcene K.
    Gohdes, Dorothy
    Hall, Taryn O.
    Harwell, Todd S.
    Helgerson, Steven D.
    Vanderwood, Karl K.
    DIABETES EDUCATOR, 2009, 35 (02): : 209 - 223
  • [24] Erectile Dysfunction in Men with Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study (DPPOS)
    Blair, Yooni
    Doherty, Lindsay
    Temprosa, Marinella
    Wessells, Hunter
    Pop-Busui, Rodica
    Gadde, Kishore M.
    Singh, Prachi
    Sarma, Aruna V.
    DIABETES, 2022, 71
  • [25] ERECTILE DYSFUNCTION IN MEN WITH PREDIABETES AND TYPE 2 DIABETES: THE DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)
    Blair, Yooni
    Doherty, Lindsay
    Temprosa, Marinella
    Wessells, Hunter
    Pop-Busui, Rodica
    Gadde, Kishore
    Singh, Prachi
    Sarma, Aruna V.
    JOURNAL OF UROLOGY, 2023, 209 : E738 - E738
  • [26] Antidepressant Medicine Use and Risk of Developing Diabetes During the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
    Rubin, Richard R.
    Ma, Yong
    Peyrot, Mark
    Marrero, David G.
    Price, David W.
    Barrett-Connor, Elizabeth
    Knowler, William C.
    DIABETES CARE, 2010, 33 (12) : 2549 - 2551
  • [27] Lifetime health economic benefits of type 2 diabetes prevention in high risk subjects in an Australian setting: an updated analysis based on the results of the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
    Palmer, A. J.
    Tucker, D. M. D.
    DIABETOLOGIA, 2010, 53 : S83 - S83
  • [28] Public Health Approaches to Type 2 Diabetes Prevention: the US National Diabetes Prevention Program and Beyond
    Gruss, Stephanie M.
    Nhim, Kunthea
    Gregg, Edward
    Bell, Miriam
    Luman, Elizabeth
    Albright, Ann
    CURRENT DIABETES REPORTS, 2019, 19 (09)
  • [29] Public Health Approaches to Type 2 Diabetes Prevention: the US National Diabetes Prevention Program and Beyond
    Stephanie M. Gruss
    Kunthea Nhim
    Edward Gregg
    Miriam Bell
    Elizabeth Luman
    Ann Albright
    Current Diabetes Reports, 2019, 19
  • [30] Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
    Lee, Christine G.
    Heckman-Stoddard, Brandy
    Dabelea, Dana
    Gadde, Kishore M.
    Ehrmann, David
    Ford, Leslie
    Prorok, Philip
    Boyko, Edward J.
    Pi-Sunyer, Xavier
    Wallia, Amisha
    Knowler, William C.
    Crandall, Jill P.
    Temprosa, Marinella
    DIABETES CARE, 2021, 44 (12) : 2775 - 2782